September 28, 2022
The University of Cincinnati's Alberto Espay, MD, was featured in an NBC News article reporting on results from a phase three Alzheimer's drug trial.
October 25, 2022
National media outlets highlighted the results of the first-in-human trial of FLASH radiotherapy, led by University of Cincinnati Cancer Center researchers.
October 10, 2022
Local 12 News and 55KRC's Simply Medicine podcast highlighted the the University of Cincinnati Gardner Neuroscience Institute's transformation into a Learning Health System, beginning with work in epilepsy.
March 9, 2023
KYTV News in Springfield, Missouri highlighted the University of Cincinnati's epilepsy transition clinic that helps guide patients as they move from pediatric to adult care.
March 13, 2023
The University of Cincinnati's Rhonna Shatz, DO, provided expert commentary to Seasons and MSN about a recent study that found taking sleeping pills could raise the risk of Alzheimer's disease.
December 20, 2022
The University of Cincinnati's Alberto Espay joined 55KRC's Simply Medicine program to discuss stiff person syndrome following singer Céline Dion's announcement she has been diagnosed with the neurological condition.
January 10, 2023
Parkinson's News Today highlighted results of a recent trial, led in the U.S. by the University of Cincinnati's Alberto Espay, that found a liquid drug formulation was more effective than an oral formulation to control symptoms of Parkinson's disease.
February 6, 2023
The University of Cincinnati Cancer Center’s Teresa Meier and Sarah Sittenfeld joined 55KRC's Simply Medicine to discuss cervical cancer, including risk factors and the importance of screenings.
February 14, 2023
The University of Cincinnati's Joseph Broderick provided comments to Medscape about new trial data that found performing endovascular thrombectomy in stroke patients with a large ischemic core is beneficial.
February 13, 2023
Several national news outlets highlighted the University of Cincinnati's Eva Mistry presenting on the results of the BEST-II trial at the International Stroke Conference.